MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
MediGene Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | -7.821M |
| September 30, 2019 | -4.489M |
| June 30, 2019 | 0.4456M |
| March 31, 2019 | -6.318M |
| December 31, 2018 | -4.941M |
| September 30, 2018 | -4.856M |
| June 30, 2018 | 2.138M |
| March 31, 2018 | -3.914M |
| December 31, 2017 | -6.053M |
| September 30, 2017 | -5.775M |
| June 30, 2017 | -7.799M |
| March 31, 2017 | -5.185M |
| December 31, 2016 | 10.45M |
| September 30, 2016 | -4.540M |
| June 30, 2016 | -8.786M |
| March 31, 2016 | -1.173M |
| December 31, 2015 | -3.113M |
| September 30, 2015 | -3.020M |
| June 30, 2015 | -3.477M |
| March 31, 2015 | -1.998M |
| December 31, 2014 | -1.548M |
| September 30, 2014 | -1.699M |
| June 30, 2014 | -3.783M |
| March 31, 2014 | -3.908M |
| December 31, 2013 | -2.336M |
| Date | Value |
|---|---|
| September 30, 2013 | -4.540M |
| June 30, 2013 | -5.305M |
| March 31, 2013 | -4.489M |
| December 31, 2012 | -2.948M |
| September 30, 2012 | -3.866M |
| June 30, 2012 | 1.693M |
| March 31, 2012 | -3.318M |
| December 31, 2011 | -4.133M |
| September 30, 2011 | -3.178M |
| June 30, 2011 | -3.232M |
| March 31, 2011 | 19.79M |
| September 30, 2010 | 3.052M |
| June 30, 2010 | -2.161M |
| March 31, 2010 | -8.229M |
| December 31, 2009 | -5.468M |
| September 30, 2009 | -6.866M |
| June 30, 2009 | -4.622M |
| March 31, 2009 | -10.81M |
| December 31, 2008 | -1.795M |
| September 30, 2008 | -10.03M |
| June 30, 2008 | -8.639M |
| March 31, 2008 | -13.59M |
| December 31, 2007 | -12.19M |
| September 30, 2007 | -10.71M |
| June 30, 2007 | -9.311M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| InflaRx NV | -2.937M |
| BioNTech SE | 12.56M |
| Immatics NV | -70.00M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |